CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-02). The draft was written by AI, the existence of all 3 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2003 · Search date 2026-08-02 · Methodology v0.6

Raw unsalted cashews, 30 g daily,
does it really help with Lower systolic blood pressure in type 2 diabetes?

30-Second Summary
C
Evidence Grade C · 48 · Safety caution
The cashew trial failed its primary glycemic outcome, and the small systolic-pressure difference was secondary
Cashews are a major tree-nut allergen and should be avoided by people with relevant allergy. Adding the tested 30 g to an existing diet also adds 182 kcal.
What the
research shows
The grade is C with 48 points. The registered primary glycemic outcome failed in a 300-person randomized trial, while the positive finding was secondary systolic blood pressure. Among 269 completers, changes were -4.9 plus or minus 13.7 versus -1.7 plus or minus 11.6 mmHg; a simple independent-groups approximation gives -3.2 mmHg with an approximate 95% CI of -6.3 to -0.2.
What the
ads claim
A secondary blood-pressure difference after failure of the primary glycemic outcome should not be expanded into established antihypertensive efficacy.
*

Useful facts when choosing a product

  • The intervention was raw, unsalted, crushed cashews at 30 g daily, providing 182 kcal. It was not roasted cashews, cashew butter, or cashew oil.
  • Adding 30 g without replacing another food increases daily energy intake by 182 kcal.
  • Cashews originated in the New World, so absence from East Asian classical texts is expected.
  • Verdict 226 is C with 43 points for pumpkin-seed oil and urinary or hair outcomes. An oil is different from raw whole cashews, and the indications also differ.
Gap Measurement · Verdict 2003 · C 48
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The 2018 Journal of Nutrition paper by Mohan and colleagues was checked against the CTRI record. Main support came from the Cashew Export Promotion Council of India and India's Department of Commerce. Samsons Trading, Kerala Nut Food, Alphonsa Cashew, the Cashew Manufacturers Association, Western India Cashew, and Intersnack also provided products or support. Public and cashew-industry funding were mixed.

02

Why this is classified as C (48)

Blood pressure is a surrogate, the positive result was secondary after failure of the registered glycemic primary outcome, completers were analyzed, and the standardized difference was only about 0.25. This yields C with 48 points.

Counterpoint. An independent trial with blood pressure as the prospective primary outcome, intention-to-treat analysis, and longer clinical-event follow-up is needed.

Rejudgment record. Cross-check applied — Paper and registry cross-checked, with approximate difference, interval, and standardized magnitude calculated from 269 completers and primary failure plus funding structure retained

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE~Statistically positive but below the threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Thirty grams of raw unsalted cashews provides 182 kcal?This is a trial-food composition fact, not a graded clinical outcome.
Raw unsalted cashews at 30 g daily lower systolic blood pressure in type 2 diabetesCA small secondary blood-pressure difference followed failure of the primary glycemic outcome.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Twelve-week parallel randomized controlled trial with completer analysis140India's Department of Commerce, Cashew Export Promotion Council, and six cashew-industry organizations or companiesNull primary glycemic outcome; secondary systolic blood pressure-4.9±13.7 versus -1.7±11.6 mmHg, p=0.04; approximate difference -3.2, 95% CI -6.3 to -0.2, d about 0.25Small positive secondary surrogate after primary failure
§

Receipt — 3 References

All 3 cited sources were verified for existence at the original page (as of 2026-08-02).

Mohan V, et al. Cashew Nut Consumption Increases HDL Cholesterol and Reduces Systolic Blood Pressure in Asian Indians with Type 2 Diabetes. J Nutr. 2018;148:63-69. DOI: 10.1093/jn/nxx001.
checked
The Journal of Nutrition full text for Mohan et al., 2018.
checked
Clinical Trials Registry - India. CTRI/2017/07/009022.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-02 · Corrections: none

Cite this verdict

Raw unsalted cashews, 30 g daily x systolic blood pressure in type 2 diabetes Evidence Grade C card
[Chamgap] Raw unsalted cashews, 30 g daily x systolic blood pressure in type 2 diabetes — Evidence Grade C·48. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/raw-unsalted-cashews-systolic-blood-pressure-type-2-diabetes/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.